HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiyuki Yamamoto Selected Research

Pelizaeus-Merzbacher Disease

4/2017An Xq22.1q22.2 nullisomy in a male patient with severe neurological impairment.
1/2017A novel PLP1 mutation F240L identified in a patient with connatal type Pelizaeus-Merzbacher disease.
3/2015A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease.
6/2014An emerging phenotype of Xq22 microdeletions in females with severe intellectual disability, hypotonia and behavioral abnormalities.
3/2013Pelizaeus-Merzbacher disease as a chromosomal disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiyuki Yamamoto Research Topics

Disease

20Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 01/2003
15Neoplasms (Cancer)
09/2022 - 06/2002
13Sclerosis
03/2016 - 01/2002
11Epilepsy (Aura)
01/2021 - 06/2002
11Seizures (Absence Seizure)
01/2017 - 08/2005
10Fibrosis (Cirrhosis)
01/2021 - 07/2003
8Vascular System Injuries
01/2017 - 02/2005
7Pyoderma Gangrenosum
05/2022 - 03/2010
7Intellectual Disability (Idiocy)
08/2017 - 06/2006
6Brain Diseases (Brain Disorder)
08/2017 - 10/2011
5Melanoma (Melanoma, Malignant)
09/2022 - 04/2014
5Pelizaeus-Merzbacher Disease
04/2017 - 03/2013
4Leukoencephalopathies
12/2021 - 11/2015
4Osteitis
11/2020 - 04/2014
4Deglutition Disorders (Dysphagia)
01/2020 - 10/2007
4Psoriatic Arthritis
03/2018 - 11/2013
4Systemic Scleroderma (Systemic Sclerosis)
01/2017 - 05/2012
4Tuberous Sclerosis (Bourneville's Disease)
10/2011 - 06/2002
3Erythema
10/2022 - 01/2008
3Neoplasm Metastasis (Metastasis)
09/2022 - 09/2010
3Chromosome Aberrations (Chromosome Abnormalities)
08/2022 - 01/2011
3Ulcer
05/2022 - 08/2014
3Inflammation (Inflammations)
12/2020 - 07/2003
3Diabetes Mellitus
10/2018 - 04/2005
3Drug Eruptions (Drug Eruption)
11/2017 - 05/2012
3Hemorrhage
08/2017 - 01/2008
3Craniosynostoses (Craniosynostosis)
11/2016 - 06/2006
3Localized Scleroderma (Morphea)
01/2016 - 09/2003
3Hypoglycemia (Reactive Hypoglycemia)
06/2015 - 04/2005
3Liver Diseases (Liver Disease)
02/2014 - 01/2007
3Renal Cell Carcinoma (Grawitz Tumor)
12/2013 - 09/2010
3Glycogen Storage Disease Type II (Pompe's Disease)
03/2012 - 10/2003
3Multiple Sclerosis
05/2006 - 06/2003
2Exfoliative Dermatitis (Erythroderma)
05/2022 - 01/2015
2Dermatomyositis (Dermatopolymyositis)
04/2022 - 11/2016
2Hemolytic Anemia
01/2022 - 01/2021
2Paraplegia (Spastic Paraplegia)
12/2021 - 07/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 07/2012
2Inborn Genetic Diseases (Disease, Hereditary)
09/2021 - 01/2019
2Pain (Aches)
03/2021 - 01/2008
2Paraproteinemias (Monoclonal Gammopathy)
03/2021 - 06/2011
2Focal Infection
01/2021 - 04/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 01/2008
2Cellulitis
11/2020 - 04/2014
2Wells syndrome
11/2020 - 03/2020
2Erythema elevatum diutinum
10/2020 - 01/2005
2Vasculitis (Vasculitides)
09/2020 - 08/2012
2Breast Neoplasms (Breast Cancer)
08/2020 - 10/2009
2Linear IgA Bullous Dermatosis
04/2020 - 01/2018
2Arthralgia (Joint Pain)
04/2020 - 02/2005
2Disease Progression
08/2018 - 12/2004
2Alopecia (Baldness)
02/2018 - 05/2012

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2005
13Bleomycin (Blenoxane)FDA LinkGeneric
01/2017 - 01/2002
8Pharmaceutical PreparationsIBA
12/2020 - 03/2009
7NucleotidesIBA
07/2019 - 12/2010
6DNA (Deoxyribonucleic Acid)IBA
09/2020 - 06/2006
6CytokinesIBA
08/2020 - 09/2003
6Extracellular Matrix ProteinsIBA
01/2017 - 09/2008
5Adalimumab (Humira)FDA Link
05/2022 - 11/2012
5Messenger RNA (mRNA)IBA
01/2021 - 09/2003
5CollagenIBA
01/2021 - 09/2003
5Tacrolimus (Prograf)FDA LinkGeneric
07/2011 - 01/2003
4Immunoglobulins (Immunoglobulin)IBA
09/2022 - 04/2004
4SteroidsIBA
06/2022 - 04/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
09/2012 - 02/2007
3EnzymesIBA
10/2022 - 05/2017
3NivolumabIBA
05/2022 - 07/2015
3AntibodiesIBA
04/2022 - 06/2016
3AutoantibodiesIBA
04/2022 - 12/2009
3LipidsIBA
09/2021 - 06/2004
3Interleukin-17 (Interleukin 17)IBA
12/2020 - 05/2014
3Immunoglobulin G (IgG)IBA
10/2020 - 06/2011
3Glucose (Dextrose)FDA LinkGeneric
10/2018 - 04/2005
3Levodopa (L Dopa)FDA LinkGeneric
01/2018 - 08/2009
3Phenobarbital (Luminal)FDA Link
08/2016 - 07/2011
3indium-bleomycinIBA
03/2016 - 07/2003
3Anticonvulsants (Antiepileptic Drugs)IBA
11/2015 - 04/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 01/2013
3Prednisolone (Predate)FDA LinkGeneric
08/2014 - 06/2011
3Amyloid (Amyloid Fibrils)IBA
12/2013 - 09/2003
3Methotrexate (Mexate)FDA LinkGeneric
07/2013 - 02/2005
3trans-sodium crocetinate (crocetin)IBA
10/2011 - 06/2002
2Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2020
2Serum Amyloid A Protein (Serum Amyloid A)IBA
10/2022 - 03/2021
2Immune Checkpoint InhibitorsIBA
05/2022 - 01/2022
2Prostaglandins AIBA
05/2022 - 12/2020
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2021 - 09/2003
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2020 - 08/2012
2Immunoglobulin A (IgA)IBA
04/2020 - 01/2018
2VancomycinFDA LinkGeneric
04/2020 - 01/2018
2Collagen Type VIIIBA
04/2020 - 01/2018

Therapy/Procedure

29Therapeutics
09/2022 - 01/2003
6Transplantation
01/2018 - 01/2007
5Injections
05/2005 - 01/2002
4Aftercare (After-Treatment)
01/2021 - 10/2007
3Radiotherapy
03/2020 - 07/2013
3Ligation
06/2015 - 01/2007
3Pancreaticoduodenectomy
05/2011 - 01/2008
2Tonsillectomy
01/2021 - 10/2015